BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3652276)

  • 1. In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci.
    Stefani S; Mezzatesta M; Oliveri S; Nicolosi VM; Russo G
    Chemioterapia; 1987 Aug; 6(4):264-8. PubMed ID: 3652276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological characterization of dactimicin: antibacterial activity towards gram-positive and gram-negative bacteria.
    Stefani S; Debbia EA; Schito GC; Russo G
    Drugs Exp Clin Res; 1989; 15(3):119-23. PubMed ID: 2752910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic.
    Stefani S; Nicoletti G; Russo G; Toscano MA
    Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of some Staphylococcus species to aminoglycosides.
    Geraci C; Stefani S; Focà A; Stassi G; Varaldo PE; Cipriani P; Giordano A
    Chemioterapia; 1985 Dec; 4(6):436-8. PubMed ID: 3854285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on lincosamide antibiotic resistance in methicillin-susceptible and -resistant staphylococci.
    Stefani S; Mezzatesta M; Gismondo MR; Romeo A; Nicoletti G
    Chemioterapia; 1986 Oct; 5(5):297-301. PubMed ID: 3641664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction between cefotetan and aminoglycosides on Staphylococcus aureus and coagulase negative staphylococci, both methicillin-susceptible and -resistant.
    Stefani S; Debbia E; Schito GC; Nicoletti G
    Chemioterapia; 1988 Jun; 7(3):151-5. PubMed ID: 3168069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
    Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
    Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
    Debbia EA; Schito GC; Stefani S; Nicoletti G
    Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of methicillin-resistant Staphylococci using the broth microdilution method].
    Rossi A; Citterio R; Braga A
    Boll Ist Sieroter Milan; 1987; 66(1):31-7. PubMed ID: 3650097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of clinical isolates to dactimicin and gentamicin.
    Bergan T
    Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of AA(6')-APH(2")Ia gene among high-level aminoglycoside resistant Enterococci and Staphylococci].
    Jarzembowski T; Michnowska-Swincow E; Wiśniewska K
    Med Dosw Mikrobiol; 2003; 55(4):309-13. PubMed ID: 15103989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
    Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
    J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in coagulase-negative staphylococci.
    Hamilton-Miller JM; Iliffe A
    J Med Microbiol; 1985 Apr; 19(2):217-26. PubMed ID: 3845121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
    Omoto S; Yoshida T; Kurebe M; Inouye S
    Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.